Long-term exposure to modestly lower LDL-c and SBP substantially reduces lifetime CV risk
Video navigation menu
- Randomisation scheme and study design 01:11
- Dose response of combined lower LDL-C and SBP 02:00
- Clinical implications 02:49
This video was recorded at ESC 2019 in Paris, France, on September 3, 2019.
Brian Ference, MD is currently Clinical Chief of the Division of Cardiovascular Medicine, Director of the Cardiovascular Genomic Research Center, and Chief of the Division of Translational Research and Clinical Epidemiology at Wayne State University. His current research utilizes the principles of Mendelian randomization to identify risk factors that have both a causal and a cumulative effect of the risk of disease in an attempt to identify targets for early intervention, and to model “naturally randomized trials” that attempt to frame and answer clinical questions when an actual clinical trial would be impractical or impossible to conduct.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.